CA Patent

CA2376016A1 — Oligonucleotide synthesis with lewis acids as activators

Assigned to Abbott Laboratories · Expires 2000-12-14 · 25y expired

What this patent protects

A process for synthesizing oligonucleotides by phosphoramidite chemistry wherein the improvement is the use of Lewis acids as activators for formatio n of the phosphorous-oxygen bond.

USPTO Abstract

A process for synthesizing oligonucleotides by phosphoramidite chemistry wherein the improvement is the use of Lewis acids as activators for formatio n of the phosphorous-oxygen bond.

Drugs covered by this patent

Patent Metadata

Patent number
CA2376016A1
Jurisdiction
CA
Classification
—
Expires
2000-12-14
Drug substance claim
No
Drug product claim
No
Assignee
Abbott Laboratories
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.